NCT02981914 2024-04-22Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell TransplantationUniversity of ChicagoPhase EARLY_PHASE1 Completed12 enrolled 11 charts
NCT03224819 2023-09-01Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)AmgenPhase EARLY_PHASE1 Terminated46 enrolled 40 charts